Oramed Pharmaceuticals ORMP Stock
Oramed Pharmaceuticals Price Chart
Oramed Pharmaceuticals ORMP Financial and Trading Overview
| Oramed Pharmaceuticals stock price | 2.23 USD |
| Previous Close | 3.86 USD |
| Open | 3.86 USD |
| Bid | 0 USD x 2200 |
| Ask | 0 USD x 1000 |
| Day's Range | 3.78 - 4.05 USD |
| 52 Week Range | 1.81 - 13.73 USD |
| Volume | 492.54K USD |
| Avg. Volume | 917.37K USD |
| Market Cap | 161.71M USD |
| Beta (5Y Monthly) | 1.774647 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.48 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.15 USD |
ORMP Valuation Measures
| Enterprise Value | 755.75K USD |
| Trailing P/E | N/A |
| Forward P/E | -8.244898 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 59.826374 |
| Price/Book (mrq) | 1.0696319 |
| Enterprise Value/Revenue | 0.28 |
| Enterprise Value/EBITDA | -0.022 |
Trading Information
Oramed Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.774647 |
| 52-Week Change | 8.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13.73 USD |
| 52 Week Low | 1.81 USD |
| 50-Day Moving Average | 3.16 USD |
| 200-Day Moving Average | 5.13 USD |
ORMP Share Statistics
| Avg. Volume (3 month) | 917.37K USD |
| Avg. Daily Volume (10-Days) | 402.02K USD |
| Shares Outstanding | 40.03M |
| Float | 36.19M |
| Short Ratio | 0.48 |
| % Held by Insiders | 5.44% |
| % Held by Institutions | 12.63% |
| Shares Short | 923.31K |
| Short % of Float | 2.52% |
| Short % of Shares Outstanding | 2.31% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1278.35% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -13.0099% |
| Return on Equity (ttm) | -19.63% |
Income Statement
| Revenue (ttm) | 2.7M USD |
| Revenue Per Share (ttm) | 0.07 USD |
| Quarterly Revenue Growth (yoy) | 0% |
| Gross Profit (ttm) | 2.7M USD |
| EBITDA | -34470000 USD |
| Net Income Avi to Common (ttm) | -29531000 USD |
| Diluted EPS (ttm) | -0.74 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 153.73M USD |
| Total Cash Per Share (mrq) | 3.84 USD |
| Total Debt (mrq) | 806K USD |
| Total Debt/Equity (mrq) | 0.54 USD |
| Current Ratio (mrq) | 31.206 |
| Book Value Per Share (mrq) | 3.777 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24342000 USD |
| Levered Free Cash Flow (ttm) | -15313250 USD |
Profile of Oramed Pharmaceuticals
| Country | United States |
| State | NY |
| City | New York |
| Address | 1185 Avenue of the Americas |
| ZIP | 10036 |
| Phone | 844 967 2633 |
| Website | https://www.oramed.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's product portfolio includes ORMD-0801 Type 2, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes; ORMD-0801, Phase 2 oral insulin capsule for non-alcoholic steatohepatitis, a progressive liver diseases; and ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.
Q&A For Oramed Pharmaceuticals Stock
What is a current ORMP stock price?
Oramed Pharmaceuticals ORMP stock price today per share is 2.23 USD.
How to purchase Oramed Pharmaceuticals stock?
You can buy ORMP shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oramed Pharmaceuticals?
The stock symbol or ticker of Oramed Pharmaceuticals is ORMP.
Which industry does the Oramed Pharmaceuticals company belong to?
The Oramed Pharmaceuticals industry is Biotechnology.
How many shares does Oramed Pharmaceuticals have in circulation?
The max supply of Oramed Pharmaceuticals shares is 40.85M.
What is Oramed Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Oramed Pharmaceuticals PE Ratio is now.
What was Oramed Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Oramed Pharmaceuticals EPS is -0.48 USD over the trailing 12 months.
Which sector does the Oramed Pharmaceuticals company belong to?
The Oramed Pharmaceuticals sector is Healthcare.
Oramed Pharmaceuticals ORMP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16823.17 USD — |
-0.05
|
6.87B USD — | 16753.22 USD — | 16979.96 USD — | — - | 6.87B USD — |
| NASDAQ Capital Market Composite RCMP | 101.6 USD — |
-3.37
|
— — | 100.61 USD — | 105.49 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 898.33 USD — |
-0.3
|
— — | 891.62 USD — | 905.39 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 20592.9 USD — |
-0.05
|
— — | 20507.27 USD — | 20784.83 USD — | — - | — — |
- {{ link.label }} {{link}}